Electronic Submission and Tracking of IRB Applications and Studies
Investigators initiate requests online via the GW Integrated Research Information Software (iRIS). The new system allows users to submit and track the status of their applications.
After Thursday, May 24, 2018, paper forms will no longer be accepted.
Use the menu on the left hand side of this page to determine which forms are required at important project milestones.
First time logging into GW iRIS? Review the Logging in for the First Time (PDF) reference guide.
When preparing submissions, please note:
- All IRB forms require the approval of the GW PI.
- All initial applications require the signature of the PI and the PI's department chair.
- All IRB applications with a MFA Faculty member as PI must obtain the signature of either Radwa Aly, Ph.D., or Mardi Gomberg-Maitland, MD, from the Office of Clinical Research.
- All PI's must be a regular faculty member or submit a PI Exception Form. Please refer to our FAQ page for more information on who is permitted to serve as PI.
- All research team members must have current CITI training completed (biomedical or social/behavioral research modules) within the past two years (citiprogram.org). New applications listing team members who do not have current CITI training will be returned. If the research is biomedical or clinical in nature, all team members are highly encouraged to also take the Good Clinical Practice (GCP) CITI training module.
- All research team members accessing protected health information (PHI) must have also completed CITI Information Privacy & Security (IPS) training (citiprogram.org).
- Unsure whether your project needs IRB review? Refer to the "When is IRB Review Needed" page.
Not sure if you need to submit a study to the IRB for approval? Find out here.
Has something changed since your most recent IRB approval?
It is recommended that one modification be approved by the IRB before another modification for the same study is submitted.
Expedited and full board studies that are continuing beyond their approved expiration date must seek continuing review. For more details, see the Renewing Studies page.
Submit a closure form if data collection is complete or if the remainder of your study involves only ongoing analysis of de-identified data. Please see the Closing Studies page for more information.
Report ALL unanticipated problems involving risks to participants in research (including both subjects and investigators).